Skip to content
2000
Volume 22, Issue 2
  • ISSN: 1567-2050
  • E-ISSN: 1875-5828

Abstract

Aim

This study aims to investigate the molecular mechanisms underlying Alzheimer’s disease (AD) by analyzing differentially expressed miRNAs and their target proteins to identify key regulatory networks and therapeutic targets.

Background

Alzheimer’s disease (AD) is a complex neurodegenerative disorder with multifaceted regulatory mechanisms involving differentially expressed miRNAs. Recent studies suggest that understanding the target proteins of these miRNAs may reveal crucial insights into AD pathology.

Objective

The objective of this study was to investigate the role of differentially expressed miRNAs in Alzheimer’s disease (AD) by identifying their target proteins and exploring the associated regulatory networks. This includes uncovering key hub proteins and their involvement in critical biological pathways linked to AD progression. Additionally, the study aims to identify transcription factors regulating these proteins and evaluate potential therapeutic compounds targeting these molecular players. By integrating these findings, the research seeks to provide a deeper understanding of AD pathogenesis and pave the way for novel therapeutic strategies to mitigate its progression.

Methods and Materials

Differentially expressed miRNAs were collected from reviews, with target proteins identified using MiRDB, STRING, and Cytoscape. Promoter and transcription factor (TF) analyses were performed using Enrichr, and potential therapeutic compounds targeting hub proteins were explored DrugBank.

Results

This study identifies key hub proteins, including TNF, PTEN, KRAS, ESR1, H3-3B, COL25A1, COL19A1, COL13A1, COL27A1, COL5A3, CCND1, FGF2, SMAD2, and PXDN, exploring their roles in AD progression. GO and KEGG pathway analyses revealed that hub proteins, including TNF, PTEN, KRAS, and ESR1, are involved in essential biological processes related to neural differentiation and signaling. Cytocluster analysis identified clusters with significant associations with AD, indicating complex interaction networks among these proteins.

Discussion

Potential therapeutic agents, including TNF inhibitors, estrogen receptor agonists, and KRAS inhibitors, were identified. Promoter and TF analysis further highlighted regulatory factors in AD pathways.

Conclusion

This study emphasizes crucial AD-related proteins and pathways, providing insights for future therapeutic targeting of gene expression to mitigate AD progression.

© 2024 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/car/10.2174/0115672050374376250416044512
2025-04-23
2025-09-13

  • From This Site

    /content/journals/car/10.2174/0115672050374376250416044512
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. ZhangJ. ZhangY. WangJ. XiaY. ZhangJ. ChenL. Recent advances in Alzheimer’s disease: mechanisms, clinical trials and new drug development strategies.Signal Transduct. Target. Ther.20249121110.1038/s41392‑024‑01911‑339174535
     [Google Scholar]
  2. KumarA. SidhuJ. GoyalA. TsaoJ.W. DoerrC. Alzheimer Disease (Nursing).StatPearls Treasure Island (FL)2021
     [Google Scholar]
  3. MiglioreL. CoppedèF. Gene–environment interactions in Alzheimer disease: The emerging role of epigenetics.Nat. Rev. Neurol.2022181164366010.1038/s41582‑022‑00714‑w36180553
     [Google Scholar]
  4. SeharU. RawatP. ReddyA.P. KopelJ. ReddyP.H. Amyloid beta in aging and Alzheimer’s disease.Int. J. Mol. Sci.202223211292410.3390/ijms23211292436361714
     [Google Scholar]
  5. PerluigiM. Di DomenicoF. ButterfieldD.A. Oxidative damage in neurodegeneration: Roles in the pathogenesis and progression of Alzheimer disease.Physiol. Rev.2024104110319710.1152/physrev.00030.202237843394
     [Google Scholar]
  6. KotarbaS. KozłowskaM. SciosM. SaramowiczK. BarczukJ. GranekZ. SiweckaN. WieseW. GolbergM. GalitaG. SychowskiG. MajsterekI. Rozpędek-KamińskaW. Potential mechanisms of tunneling nanotube formation and their role in pathology spread in Alzheimer’s disease and other proteinopathies.Int. J. Mol. Sci.202425191079710.3390/ijms25191079739409126
     [Google Scholar]
  7. AbuAlrobM. Neuroinflammation in Alzheimer’s disease: Mechanistic insights, pathological implications, and emerging therapeutic strategies.Authorea202410.22541/au.172838938.84403346/v1
     [Google Scholar]
  8. BagyinszkyE. AnS.S.A. Haploinsufficiency and Alzheimer’s disease: The possible pathogenic and protective genetic factors.Int. J. Mol. Sci.202425221195910.3390/ijms25221195939596030
     [Google Scholar]
  9. EkundayoB.E. ObafemiT.O. AdewaleO.B. ObafemiB.A. OyinloyeB.E. EkundayoS.K. Oxidative stress, endoplasmic reticulum stress and apoptosis in the pathology of Alzheimer’s disease.Cell Biochem. Biophys.202482245747710.1007/s12013‑024‑01248‑238472715
     [Google Scholar]
  10. AbdelmaksoudN.M. SallamA.A.M. AbulsoudA.I. El-DakrouryW.A. Abdel MageedS.S. AL-NoshokatyT.M. ElrebehyM.A. ElshaerS.S. MahmoudN.A. FathiD. RizkN.I. ElballalM.S. MohammedO.A. Abdel-ReheimM.A. ZakiM.B. SaberS. DoghishA.S. Unraveling the role of miRNAs in the diagnosis, progression, and therapeutic intervention of Alzheimer’s disease.Pathol. Res. Pract.202425315500710.1016/j.prp.2023.15500738061270
     [Google Scholar]
  11. LiangY. WangL. Inflamma-microRNAs in Alzheimer’s disease: From disease pathogenesis to therapeutic potentials.Front. Cell. Neurosci.20211578543310.3389/fncel.2021.78543334776873
     [Google Scholar]
  12. LeeC.Y. RyuI.S. RyuJ.H. ChoH.J. miRNAs as therapeutic tools in Alzheimer’s disease.Int. J. Mol. Sci.202122231301210.3390/ijms22231301234884818
     [Google Scholar]
  13. Mottaghi-DastjerdiN. GhorbaniA. MontazeriH. GuzziP.H. A systems biology approach to pathogenesis of gastric cancer: Gene network modeling and pathway analysis.BMC Gastroenterol.202323124810.1186/s12876‑023‑02891‑437482618
     [Google Scholar]
  14. HenekaM.T. CarsonM.J. KhouryJ.E. LandrethG.E. BrosseronF. FeinsteinD.L. JacobsA.H. Wyss-CorayT. VitoricaJ. RansohoffR.M. HerrupK. FrautschyS.A. FinsenB. BrownG.C. VerkhratskyA. YamanakaK. KoistinahoJ. LatzE. HalleA. PetzoldG.C. TownT. MorganD. ShinoharaM.L. PerryV.H. HolmesC. BazanN.G. BrooksD.J. HunotS. JosephB. DeigendeschN. GaraschukO. BoddekeE. DinarelloC.A. BreitnerJ.C. ColeG.M. GolenbockD.T. KummerM.P. Neuroinflammation in Alzheimer’s disease.Lancet Neurol.201514438840510.1016/S1474‑4422(15)70016‑525792098
     [Google Scholar]
  15. PlantoneD. PardiniM. RighiD. MancoC. ColomboB.M. De StefanoN. The role of TNF-α in Alzheimer’s disease: A narrative review.Cells20231315410.3390/cells1301005438201258
     [Google Scholar]
  16. Ortí-CasañN. ZuhornI.S. NaudéP.J.W. De DeynP.P. van SchaikP.E.M. WajantH. EiselU.L.M. A TNF receptor 2 agonist ameliorates neuropathology and improves cognition in an Alzheimer’s disease mouse model.Proc. Natl. Acad. Sci. USA202211937e220113711910.1073/pnas.220113711936037389
     [Google Scholar]
  17. GaneyP.E. MisekS.A. Cellular Signal Transduction in Toxicology and Pharmacology: Data Collection, Analysis, and Interpretation.Wiley, 2019, 73.10.1002/9781119060208.ch4
  18. KirouacL. RajicA.J. CribbsD.H. PadmanabhanJ. Activation of Ras-ERK signaling and GSK-3 by amyloid precursor protein and amyloid beta facilitates neurodegeneration in Alzheimer’s disease.eNeuro201742ENEURO.0149-16.201710.1523/ENEURO.0149‑16.201728374012
     [Google Scholar]
  19. QianX. LiuX. ChenS. TangH. Identification of immune hub genes associated with braak stages in Alzheimer’s disease and their correlation of immune infiltration.Front. Aging Neurosci.20221488716810.3389/fnagi.2022.88716835619939
     [Google Scholar]
  20. SatoK. TakayamaK. InoueS. Expression and function of estrogen receptors and estrogen-related receptors in the brain and their association with Alzheimer’s disease.Front. Endocrinol.202314122015010.3389/fendo.2023.122015037469978
     [Google Scholar]
  21. KiyotaT. IngrahamK.L. JacobsenM.T. XiongH. IkezuT. FGF2 gene transfer restores hippocampal functions in mouse models of Alzheimer’s disease and has therapeutic implications for neurocognitive disorders.Proc. Natl. Acad. Sci. USA201110849E1339E134810.1073/pnas.110234910822042871
     [Google Scholar]
  22. ChenS. ZhengY. XiaoJ. LinS. ChenD. LiS. FGF2 shows therapeutic effects in Alzheimer’s disease animal model via suppressing PI3K/Akt mediated ER stress.Int. J. Clin. Exp. Med.2016921302138
     [Google Scholar]
  23. ChenX. LiZ. ChengY. KardamiE. LohY.P. Low and high molecular weight FGF-2 have differential effects on astrocyte proliferation, but are both protective against Aβ-induced cytotoxicity.Front. Mol. Neurosci.20201232810.3389/fnmol.2019.0032832038161
     [Google Scholar]
  24. LiangJ. WangC. ZhangH. HuangJ. XieJ. ChenN. Exercise-induced benefits for Alzheimer’s disease by stimulating mitophagy and improving mitochondrial function.Front. Aging Neurosci.20211375566510.3389/fnagi.2021.75566534658846
     [Google Scholar]
  25. KleinC.J. BenarrochE.E. Epigenetic regulation.Neurology201482201833184010.1212/WNL.000000000000044024759839
     [Google Scholar]
  26. StevanovicM. DrakulicD. LazicA. NinkovicD.S. SchwirtlichM. MojsinM. SOX transcription factors as important regulators of neuronal and glial differentiation during nervous system development and adult neurogenesis.Front. Mol. Neurosci.20211465403110.3389/fnmol.2021.65403133867936
     [Google Scholar]
  27. KashimaR. HataA. The role of TGF-β superfamily signaling in neurological disorders.Acta Biochim. Biophys. Sin.201850110612010.1093/abbs/gmx12429190314
     [Google Scholar]
  28. ChakrabartiM. McDonaldA.J. Will ReedJ. MossM.A. DasB.C. RayS.K. Molecular signaling mechanisms of natural and synthetic retinoids for inhibition of pathogenesis in Alzheimer’s disease.J. Alzheimers Dis.201650233535210.3233/JAD‑15045026682679
     [Google Scholar]
  29. UddinM.S. RahmanM.M. JakariaM. RahmanM.S. HossainM.S. IslamA. AhmedM. MathewB. OmarU.M. BarretoG.E. AshrafG.M. Estrogen signaling in Alzheimer’s disease: Molecular insights and therapeutic targets for Alzheimer’s dementia.Mol. Neurobiol.20205762654267010.1007/s12035‑020‑01911‑832297302
     [Google Scholar]
/content/journals/car/10.2174/0115672050374376250416044512
Loading
Unraveling the Intricacies: The Role of miRNAs in the Progression and Initiation of Alzheimer's Disease
Curr Alzheimer Res 22, 152 (2025); https://doi.org/10.2174/0115672050374376250416044512
/content/journals/car/10.2174/0115672050374376250416044512
/content/journals/car/10.2174/0115672050374376250416044512
Loading

Data & Media loading...


  • Article Type:     Research Article
Keyword(s): Alzheimer’s disease; gene regulation; MicroRNA; protein-protein interaction networks; therapeutic targeting; transcription factor

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test